This knowledge will be valuable for researchers in diverse fields, enabling them to explore the potential of GnRH antagonists in other hormone-dependent cancers, such as breast, ovarian, endometrial, and uterine fibroids. The gene discussed is GNRH1; the disease is uterine corpus leiomyoma.